The importance of diversity in clinical trials for hepatitis C

Interactive Patient Journey: Hepatitis C

Why hepatitis C is called a "quiet killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.

Who is at risk for Hepatitis C?

Learn who has higher odds of contracting this viral infection.

My story: my hepatitis C journey as a black American

Pat, a hepatitis C survivor, shares her thoughts on disparity within the healthcare system.

How blood transfusions for sickle cell may have impacted hepatitis C rates among black americans

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.

Patient perspectives: understanding healthcare equity as a provider, patient, or person of color

From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.